VIIN Young Investigator Symposium 2025
| Date | 14 November - 14 November 2025 |
| Time | 8am - 7pm |
| Venue | Monash Institute of Pharmaceutical Sciences, Parkville |
| Location | Parkville View Map |
| iCal | Add to Calendar |
On Friday 14 November 2025, the VIIN Young Investigator Symposium is back for another stellar showcase of emerging talent!
In 2025, we are again delighted to be holding the YIS at the Monash Institute of Pharmaceutical Sciences (MIPS). We thank MIPS for their kind support in hosting us.
The purpose of the Young Investigator Symposium is to provide students, RAs and postdocs a forum for networking, career development and scientific exchange. We hope it will provide you with an opportunity to keep in touch with colleagues, present your research, and develop your CVs.
Prizes will be awarded for best presentations.
All welcome - undergraduate and post-graduate students, research assistants, post-doctoral scientists from academic and industry. Mid-career researchers and research group leaders are encouraged to attend and support their students or colleagues. We hope to see you all there!
Sponsors and Prizes:
To sponsor a prize, exhibit or advertise at the VIIN Young Investigator Symposium 2025, please contact the VIIN Program Manager at info@viin.org.au
Registration and abstract submissions now open!
Registration (open 16 July 2025 - 31 October 2025)
Register here (via TryBooking)
Abstract submission instructions:
Abstract submissions open 16 July 2025 - 29 August 2025
Top tips for preparing your abstract >> Download here
(1) Submit abstracts for oral and poster presentations by 5pm AEST on Friday 29 August 2025. No late submissions will be accepted.
(2) Download and complete your Abstract Submission template here. Complete the Abstract Submission template using exactly the format provided. Please do not change font size or style.
(3) Save the Abstract Submission template in PDF.
(4) Name the Abstract Submission in the following format: FAMILY-NAME_FIRST-NAME_BEST-FIT-CATEGORY.PDF
e.g. Nguyen_Bill_Adaptive Immunology.PDF. (See point 6 about Best Fit Category.)
(5) Click here to submit your abstract and participant information by Google Form.
Please note that you need a Gmail account to access the abstract submission form. Setting up a Gmail account is free and quick: https://accounts.google.com/signup/v2/webcreateaccount
(6) When submitting your Abstract, you will be required to select two Abstract submission categories under which your Abstract will be peer-reviewed. You need to select a Best Fit category and a Second Best Fit category, which must be different. To help you best answer this question before you come to submitting your abstract, this is the list to select from:
- Adaptive immunology
- Clinical (including vaccines, therapeutics, diagnostics)
- COVID-19, emerging infections or global health
- Host-pathogen interactions
- Innate immunology or inflammation
- Microbiota or host-microbiota interactions
- Pathogens (including bacteria, viruses, parasites, fungi)
- Public health
- Other
- Systems or structural biology
- Tissue-specific or cancer immunology
Additional step for submitters who do not consent to having their abstracts published:
(7) If you DO NOT agree to have your abstract published in the electronic abstract booklet, please prepare and submit a second PDF.
Like the one prepared in steps (2) - (4), you should use the Abstract Submission template here. This must contain your Abstract Title, Author List, * = presenting author information, but then the words "PUBLISH CONSENT WITHHELD." Name the Abstract Submission in the following format: FAMILY-NAME_FIRST-NAME_BEST-FIT-CATEGORY.PDF e.g. Nguyen_Bill_Adaptive Immunology.PDF. There will be a second upload option in the Google Form to use for this file.
Additional step for submitters who do science communication on social media:
(8) Graphical abstracts may also be submitted using the Google form (optional). If you elect to submit a graphical abstract, this may be used on VIIN social media accounts on BlueSky, LinkedIn or X (Twitter) to promote your talk.
Accordingly, do not include any data or confidential information in your file. You may like to consider using your title slide, a professional photograph of yourself, or the lab you belong to, or, where relevant, a lifecycle, cell diagram or signalling pathway that illustrates a key element of your work. If you provide this information, it is with the understanding that we may tag you and your organisation in a social media post including this graphic.
Instructions: Submit a JPEG or PNG file. Name the Graphical Abstract in the following format: GRAPHICAL ABSTRACT_FAMILY-NAME_FIRST-NAME.PDF e.g. GRAPHICAL ABSTRACT_Brown_Jane.JPG.
Following submission of your abstract, you will receive a copy of your form responses, and confirmation as follows:
Thank you for submitting your abstract for the 2025 VIIN Young Investigator Symposium.
We appreciate your interest. If there are issues with the formatting or content of your form and abstract, we'll be in touch. Otherwise, please be assured that we have received your submission and that it will be peer-reviewed for presentation at the YIS.
An announcement will be made on the 2025 VIIN Young Investigator Symposium event page on the VIIN website on Friday 3 October after 12pm about the type of presentation you have been allocated.
Please check the site after this time and date to determine what sort of presentation to prepare. We will be unable to contact individual submitters to inform them of their presentation type and would ask you rely on the website for further information.
Further instructions about how to prepare your poster, Science Bite or oral presentation will be made available at the same time. ALL TALKS, whether oral presentations or Science Bites, will need to be sent through for compilation prior to the Symposium: we would ask that you take particular note of these deadlines.
If you have questions or concerns that aren't answered here, please contact info@viin.org.au.
2025 Organising Committee:
Dr Aaron Brice (Co-Chair), Australian Centre for Disease Preparedness CSIRO
Dr Stella Liong (Co-Chair), Centre for Respiratory Science and Health, School of Health and Biomedical Sciences, RMIT University
Dr Thomas Angelovich, School of Health and Biomedical Sciences, RMIT University
Dr Sarah Ashley, Infection, Immunity and Global Health, Murdoch Children's Research Institute (MCRI)
Dr Marine Besnard, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Monash University
Dr Dimitra Chatzileontiadou, La Trobe Institute for Molecular Science (LIMS), La Trobe University
Dr Sandra Chishimba, Burnet Institute
Dr Michelle Chonwerawong, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research
Dr Sam Davis, Immune Resilience Future Science Platform, CSIRO
Dr Emily Eriksson, Walter and Eliza Hall Institute of Medical Research
Dr Isabelle Foo, Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, University of Melbourne
Dr Paul Gill, Department of Immunology, Alfred Hospital, Monash University
Dr Robson Kriiger Loterio, Burnet Institute
Dr Kevin Lee, Department of Medicine, Royal Melbourne HospitalUniversity of Melbourne
Dr Christophe Macri, Bio21 Institute, Department of Biochemistry and Pharmacology, University of Melbourne
Dr Kitty McCaffrey, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research
Dr Damian Oyong, Life Sciences Discipline (Disease Elimination), Burnet Institute
Dr Louis Perriman, Murdoch Children's Research Institute (MCRI), Fiona Elsey Cancer Research Institute (FECRI)
Dr Ashleigh Rogers, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University
Dr Sampa Sarkar, School of Science, RMIT University
Dr Natalia Sampaio, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research
Dr Simona Seizova, Walter and Eliza Hall Institute of Medical Research
Dr Helen Stölting, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery InstituteMonash University
Dr Isabella Stuart, Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, University of Melbourne
Dr Caroline Soliman, Biopharmaceutical Product Development (R&D), CSL Innovation, University of Melbourne
Dr Praveena Thirunavukkarasu, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University
Dr Ryan Toh, Murdoch Children's Research Institute (MCRI)
Dr Naveen Vankadari, Bio21 InstituteDepartment of Biochemistry and Pharmacology, University of Melbourne
Dr Kayla Wilson, Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, University of Melbourne
Dr Jinxin Zhao, Department of MicrobiologyMonash Biomedicine Discovery Institute, Monash University
Madeleine Wemyss, VIIN Project Officer
